Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Lars Iversen, MD, DMSc
Aarhus University Hospital
Aarhus, Denmark
IPC Board Member

Professor Iversen, an IPC councilor since 2009, and since 2017 board member of the IPC. He is professor in dermatology at the University of Aarhus, Denmark, where he also teaches dermato-venereology. He received his clinical education and obtained a doctoral degree from the same university. Professor Iversen's main research interests are psoriasis and cutaneous T-cell lymphoma. Most of his research activities are related to signal transduction and immunology. Professor Iversen has served as a guest researcher and has been a speaker at international conferences in Asia, Europe and the United States. He is the author or co-author of 240 articles and book chapters and the holder of two patents. He has served as a section editor for Acta Dermato-Venereologica and on the editorial board of Experimental Dermatology. His writings have appeared in several scientific journals including Nature Immunology, Nature Communications, PNAS, EMBO Journal and Journal of Allergy and Clinical Immunology. In 2019 professor Iversen was the founder of the National Center for Autoimmune Diseases at Aarhus University Hospital in Denmark.

Last Updated: May 21, 2021



Claudio Fiocchi, MD
Cleveland Clinic Lerner College of Medicine, Cleveland and Lerner Research Institute of the Cleveland Clinic.
Cleveland, Ohio, United States

Dr. Fiocchi obtained his medical degree from the Santa Casa Faculty of Medicine in São Paulo, Brazil, followed by training in internal medicine, immunology and gastroenterology in São Paulo, Baltimore, and Cleveland. Currently Dr. Fiocchi is Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine, Cleveland, and a staff member of the Department of Inflammation & Immunity in the Lerner Research Institute of the Cleveland Clinic.

His lifelong research interest is the pathogenesis of inflammatory bowel disease (IBD), where he has made numerous contributions. These included the investigation of immune events occurring in the bowel of Crohn's disease and ulcerative colitis patients, as well as animal models of IBD. The studies included the identification of mechanisms of mucosal T-cell death and survival, investigation of tolerance of mucosal T-cells for the autologous enteric flora, characterization of the interactions between mucosal T-cells and endothelial and stromal cells, and the study of immune-driven angiogenesis in intestinal inflammation. His most recent area of interest is the use of systems biology and network medicine to understand IBD pathogenesis in a more comprehensive fashion.

Dr. Fiocchi has received numerous recognitions and awards as well as serving as Associate Editor or Editorial Board member of several journals.

Last Updated: May 12, 2021

Catherine Smith, MD
St John's Institute of Dermatology, Guys and St Thomas's Hospitals
London, England, United Kingdom
IPC Board Member

Catherine is Professor of Dermatology and Therapeutics and Consultant Dermatologist at St John’s Institute of Dermatology, Kings College London and Guys and St Thomas’ Hospital.  She co-directs the Skin Therapy Research Unit, and is also a lead clinician in national specialised services for adults with severe psoriasis. Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involve major national and international collaboration.  She also has a major interest in guideline development and implementation in the UK and Europe, with the aim of bringing research findings into clinical practice.

Last Updated: May 27, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.